AI in Medical Diagnostics: Global Markets
Report Scope:
The current report offers a detailed picture of the AI medical diagnostics market.
This report highlights the current and future market potential for AI medical diagnostics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, and trends in the market. The report also covers market projections through 2026, as well as key market players.
This report discusses the AI medical diagnostics market and its various resources. It covers the overall AI medical diagnostics market including hardware, software and analytics, and services. The report further analyzes the market based on application, providing an analysis of oncology, cardiology, neurology, orthopedic and others. In addition, the report also analyses various modalities of diagnostics imaging including MRI, CT scans, ultrasounds, X-rays and others (ECG, EEG, etc.). Furthermore, a complete regional analysis of the market is also studied in the report.
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World (which includes Latin America, and the Middle East and Africa). Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2020 as the base year, with forecasts for 2021 through 2026. Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Includes:
The current report offers a detailed picture of the AI medical diagnostics market.
This report highlights the current and future market potential for AI medical diagnostics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, and trends in the market. The report also covers market projections through 2026, as well as key market players.
This report discusses the AI medical diagnostics market and its various resources. It covers the overall AI medical diagnostics market including hardware, software and analytics, and services. The report further analyzes the market based on application, providing an analysis of oncology, cardiology, neurology, orthopedic and others. In addition, the report also analyses various modalities of diagnostics imaging including MRI, CT scans, ultrasounds, X-rays and others (ECG, EEG, etc.). Furthermore, a complete regional analysis of the market is also studied in the report.
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World (which includes Latin America, and the Middle East and Africa). Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2020 as the base year, with forecasts for 2021 through 2026. Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Includes:
- 68 data tables and 67 additional tables
- A brief general outlook of the global market for artificial intelligence (AI) in medical diagnostics
- Analyses of the global market trends, with historic data from 2019 and 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the global AI medical diagnostics market size, and corresponding market share analysis by component, medical specialty application area, end-user, treatment modality, and geographic region
- Technology assessment of the key drivers, restraints and opportunities that will shape the market for AI medical diagnostics over the next five years (2021 to 2026)
- Country specific data and market value analysis for the U.S., Canada, France, Germany, U.K., Italy, Spain, China, India, Japan and other emerging economies
- Identification of key artificial intelligence technologies and products with the greatest commercial potential, and relevant applications of various AI tools in medical diagnosis, breakthrough therapies and patient health management
- Highlights of the COVID-19 impact on the global AI medical diagnostics market as well as the overall MedTech industry
- Insight into recent industry structure, current competitive scenario, R&D activities, regulatory and legislative issues, and product launch strategies currently focused on AI technologies
- Patent activity and review of patent grants for AI medical diagnostics across each major category
- Understanding of the start-up ecosystem and competitor dashboard for key market participants in global AI medical diagnostics market
- Descriptive company profiles of the leading market players, including Canon Medical System Corp., GE Healthcare, Intel, IBM Corp., Nano-X Imaging Ltd., Siemens Healthcare GmbH, and Subtle Medical, Inc.
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Introduction to Artificial Intelligence
Understanding Artificial Intelligence in Healthcare
Artificial Intelligence in Healthcare Evolution and Transition
Defining Artificial Intelligence in Medical Diagnostics
Disease Detection and Diagnostics
Industry Structure
Data Warehouse
Artificial Intelligence (AI) Analysis
Software Development
List of FDA-Approved AI and Machine Learning-Enabled Medical Devices/Diagnostics Devices and Algorithms
AI and Machine Learning-Enabled Medical Devices/Radiology and Other Imaging Modalities
Artificial Intelligence and Machine Learning (AI/ML) Algorithms
CHAPTER 4 MARKET DYNAMICS
Drivers
Investment in AI Health Sector
Increasing Strategic Moves by Market Players
Rising Incidence of Chronic Diseases
Restraints and Challenges
Reluctance Among Medical Practitioners to Adopt AI-Based Technologies
Ambiguous Regulatory Guidelines for Medical Software
Challenge To Maintain Data Security
Opportunities
Integration of Software with Artificial Intelligence
Untapped Potential in Emerging Markets
CHAPTER 5 IMPACT OF COVID-19 ON THE AI MEDICAL DIAGNOSTICS MARKET
Introduction
Regulatory Delays, Clinical Trials and Product Launches
Supply Chain Disruptions
Impact on MedTech
Impact on AI Medical Diagnostics
Home-Based Pathology
CHAPTER 6 GLOBAL MARKET FOR AI MEDICAL DIAGNOSTICS BY COMPONENT
Software
Services
Hardware
CHAPTER 7 GLOBAL MARKET FOR AI MEDICAL DIAGNOSTICS BY MEDICAL SPECIALTY APPLICATION AREA
Oncology
Cardiology
Neurology
Orthopedics
Others
CHAPTER 8 GLOBAL MARKET FOR AI MEDICAL DIAGNOSTICS BY END USER
Hospitals and Clinics
Diagnostic Imaging Centers and Diagnostic Laboratories
CHAPTER 9 GLOBAL MARKET FOR AI MEDICAL DIAGNOSTICS BY MODALITY
MRI
CT Scans
Common Applications of CT Scans
Application of CT in Pediatric Patients
Benefits
Ultrasound
X-Rays
Advantages of X-Ray Machines
Others
CHAPTER 10 GLOBAL MARKET FOR AI MEDICAL DIAGNOSTICS BY REGION
North America
United States
Canada
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
CHAPTER 11 REGULATORY FRAMEWORK
Regulatory Framework
American Diabetes Association's Standards of Medical Care in Diabetes
ATA Guidelines for Artificial Intelligence (AI)
Indian AI Guidelines, Strategy and Standards
CHAPTER 12 PATENT REVIEW
Introduction
Patent Review
Companies Granted Patents in AI Medical Diagnostics
Patent Review by Geography
CHAPTER 13 START-UP ECOSYSTEM
Introduction
CHAPTER 14 COMPETITIVE LANDSCAPE ANALYSIS
Primary Strategies: Partnerships, Collaborations, Agreements and Contracts
FDA/CE Mark/EU Approval: Secondary Strategy
Review of Company Strategies Used
CHAPTER 15 COMPANY PROFILES
AIDOC MEDICAL LTD.
ARTERYS INC.
BEHOLD.AI TECHNOLOGIES LTD.
BUTTERFLY NETWORK
CANON MEDICAL SYSTEM CORP.
CAPTION HEALTH
DEEPMIND TECHNOLOGIES LTD.
DIGITAL DIAGNOSTICS
ENLITIC INC.
FUJIFILM HOLDING CORP.
GE HEALTHCARE
HEURON CO., LTD.
IMAGEN TECHNOLOGIES
INTERNATIONAL BUSINESS MACHINES CORP. (IBM)
ICARBONX
INTEL CORP.
MEDTRONIC PLC
MICROSOFT CORP.
NANO-X IMAGING LTD.
NVIDIA
PHILIPS HEALTHCARE
QURE.AI
ROCHE HOLDING AG
SAMSUNG ELECTRONICS INC.
SIEMENS HEALTHCARE
SUBTLE MEDICAL, INC.
SYNAPSICA
XILINX, INC.
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Introduction to Artificial Intelligence
Understanding Artificial Intelligence in Healthcare
Artificial Intelligence in Healthcare Evolution and Transition
Defining Artificial Intelligence in Medical Diagnostics
Disease Detection and Diagnostics
Industry Structure
Data Warehouse
Artificial Intelligence (AI) Analysis
Software Development
List of FDA-Approved AI and Machine Learning-Enabled Medical Devices/Diagnostics Devices and Algorithms
AI and Machine Learning-Enabled Medical Devices/Radiology and Other Imaging Modalities
Artificial Intelligence and Machine Learning (AI/ML) Algorithms
CHAPTER 4 MARKET DYNAMICS
Drivers
Investment in AI Health Sector
Increasing Strategic Moves by Market Players
Rising Incidence of Chronic Diseases
Restraints and Challenges
Reluctance Among Medical Practitioners to Adopt AI-Based Technologies
Ambiguous Regulatory Guidelines for Medical Software
Challenge To Maintain Data Security
Opportunities
Integration of Software with Artificial Intelligence
Untapped Potential in Emerging Markets
CHAPTER 5 IMPACT OF COVID-19 ON THE AI MEDICAL DIAGNOSTICS MARKET
Introduction
Regulatory Delays, Clinical Trials and Product Launches
Supply Chain Disruptions
Impact on MedTech
Impact on AI Medical Diagnostics
Home-Based Pathology
CHAPTER 6 GLOBAL MARKET FOR AI MEDICAL DIAGNOSTICS BY COMPONENT
Software
Services
Hardware
CHAPTER 7 GLOBAL MARKET FOR AI MEDICAL DIAGNOSTICS BY MEDICAL SPECIALTY APPLICATION AREA
Oncology
Cardiology
Neurology
Orthopedics
Others
CHAPTER 8 GLOBAL MARKET FOR AI MEDICAL DIAGNOSTICS BY END USER
Hospitals and Clinics
Diagnostic Imaging Centers and Diagnostic Laboratories
CHAPTER 9 GLOBAL MARKET FOR AI MEDICAL DIAGNOSTICS BY MODALITY
MRI
CT Scans
Common Applications of CT Scans
Application of CT in Pediatric Patients
Benefits
Ultrasound
X-Rays
Advantages of X-Ray Machines
Others
CHAPTER 10 GLOBAL MARKET FOR AI MEDICAL DIAGNOSTICS BY REGION
North America
United States
Canada
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
CHAPTER 11 REGULATORY FRAMEWORK
Regulatory Framework
American Diabetes Association's Standards of Medical Care in Diabetes
ATA Guidelines for Artificial Intelligence (AI)
Indian AI Guidelines, Strategy and Standards
CHAPTER 12 PATENT REVIEW
Introduction
Patent Review
Companies Granted Patents in AI Medical Diagnostics
Patent Review by Geography
CHAPTER 13 START-UP ECOSYSTEM
Introduction
CHAPTER 14 COMPETITIVE LANDSCAPE ANALYSIS
Primary Strategies: Partnerships, Collaborations, Agreements and Contracts
FDA/CE Mark/EU Approval: Secondary Strategy
Review of Company Strategies Used
CHAPTER 15 COMPANY PROFILES
AIDOC MEDICAL LTD.
ARTERYS INC.
BEHOLD.AI TECHNOLOGIES LTD.
BUTTERFLY NETWORK
CANON MEDICAL SYSTEM CORP.
CAPTION HEALTH
DEEPMIND TECHNOLOGIES LTD.
DIGITAL DIAGNOSTICS
ENLITIC INC.
FUJIFILM HOLDING CORP.
GE HEALTHCARE
HEURON CO., LTD.
IMAGEN TECHNOLOGIES
INTERNATIONAL BUSINESS MACHINES CORP. (IBM)
ICARBONX
INTEL CORP.
MEDTRONIC PLC
MICROSOFT CORP.
NANO-X IMAGING LTD.
NVIDIA
PHILIPS HEALTHCARE
QURE.AI
ROCHE HOLDING AG
SAMSUNG ELECTRONICS INC.
SIEMENS HEALTHCARE
SUBTLE MEDICAL, INC.
SYNAPSICA
XILINX, INC.
LIST OF TABLES
Summary Table: Global Market for AI Medical Diagnostics, by Region, Through 2026
Table 1: FDA-Cleared AI Radiology and Other Imaging Modalities in the U.S., 2018-2021
Table 2: FDA-Approved AI Algorithms for Radiology and Medical Imaging in the U.S., 2018-2021
Table 3: Global Leading Causes of Burden of Disease, 2004 and 2030
Table 4: Cancer Statistics Across Major Asian Countries, by Cancer Site/Type, 2020
Table 5: Global Market for AI Medical Diagnostics, by Component, Through 2026
Table 6: Global Market for AI Software in Medical Diagnostics, by Region, Through 2026
Table 7: Global Market for AI Services in Medical Diagnostics, by Region, Through 2026
Table 8: Global Market for AI Hardware in Medical Diagnostics, by Region, Through 2026
Table 9: Global Market for AI Medical Diagnostics, by Medical Specialty Application Area, Through 2026
Table 10: Global Deaths from Cancer, 2015 and 2030
Table 11: Global Market for AI Medical Diagnostics in Oncology, by Region, Through 2026
Table 12: Recent Examples of Machine Learning in Cardiology
Table 13: Global Deaths from CVD, 2015 and 2030
Table 14: Global Market for AI Medical Diagnostics in Cardiology, by Region, Through 2026
Table 15: Number of DALYs for Neurological Disorders and as Share of Global DALYs Projected for 2005 and 2030
Table 16: Deaths Attributable to Neurological Disorders, 2005 and 2030
Table 17: Global Market for AI Medical Diagnostics in Neurology, by Region, Through 2026
Table 18: Global Percentage Distribution of Population Aged Above 65, by Region, 2015 and 2050
Table 19: Global Market for AI Medical Diagnostics in Orthopedics, by Region, Through 2026
Table 20: Global Market for AI Medical Diagnostics in Other Disease Treatments, by Region, Through 2026
Table 21: Global Market for AI Medical Diagnostics, by End User, Through 2026
Table 22: Number of Hospitals in the U.S., by Type, 2020
Table 23: Global Market for AI in Hospitals and Clinics, by Region, Through 2026
Table 24: Global Market for AI Medical Diagnostics in Diagnostic Imaging Centers and Diagnostic Laboratories, by Region, Through 2026
Table 25: Global Market for AI Medical Diagnostics, by Modality, Through 2026
Table 26: Global Market for AI-Based MRI Scans, by Region, Through 2026
Table 27: Global Market for AI-Based CT Scans, by Region, Through 2026
Table 28: Some Major Uses of Ultrasound
Table 29: Global Market for AI-Based Ultrasound, by Region, Through 2026
Table 30: Global Market for AI-Based X-Rays, by Region, Through 2026
Table 31: Global Market for AI-Based Other Imaging Techniques, by Region, Through 2026
Table 32: Global Market for AI Medical Diagnostics, by Region, Through 2026
Table 33: North American Market for AI Medical Diagnostics, by Component, Through 2026
Table 34: North American Market for AI Medical Diagnostics, by Medical Specialty Application Area, Through 2026
Table 35: North American Market for AI Medical Diagnostics, by Modality, Through 2026
Table 36: North American Market for AI Medical Diagnostics, by End User, Through 2026
Table 37: North American Market for AI Medical Diagnostics, by Country, Through 2026
Table 38: Top Funded AI Start-ups in the United States, 2021
Table 39: Confirmed Cases of COVID-19 in Europe, by Country, as of December, 2021
Table 40: European Market for AI Medical Diagnostics, by Component, Through 2026
Table 41: European Market for AI Medical Diagnostics, by Medical Specialty Application Area, Through 2026
Table 42: European Market for AI Medical Diagnostics, by Modality, Through 2026
Table 43: European Market for AI Medical Diagnostics, by End User, Through 2026
Table 44: European Market for AI Medical Diagnostics, by Country, Through 2026
Table 45: Start-ups in the German Market for AI Medical Diagnostics
Table 46: Start-ups in the French Market for AI Medical Diagnostics
Table 47: Start-ups in the Spanish Market for AI Medical Diagnostics
Table 48: Start-ups in the Rest of European Market for AI Medical Diagnostics
Table 49: Asia-Pacific Market for AI Medical Diagnostics, by Component, Through 2026
Table 50: Asia-Pacific Market for AI Medical Diagnostics, by Medical Specialty Application Area, Through 2026
Table 51: Asia-Pacific Market for AI Medical Diagnostics, by Modality, Through 2026
Table 52: Asia-Pacific Market for AI Medical Diagnostics, by End User, Through 2026
Table 53: Asia-Pacific Market for AI Medical Diagnostics, by Countries, Through 2026
Table 54: Japanese Market Statistics
Table 55: Number of New Cancer Cases in Japan in Both Sexes, by All Age Groups, 2020
Table 56: Funding of AI Diagnostics Start-ups in Rest of Asia-Pacific Countries
Table 57: Rest of the World Market for AI Medical Diagnostics, by Component, Through 2026
Table 58: Rest of the World Market for AI Medical Diagnostics, by Medical Specialty Application Area, Through 2026
Table 59: Rest of the World Market for AI Medical Diagnostics, by Modality, Through 2026
Table 60: Rest of the World Market for AI Medical Diagnostics, by End User, Through 2026
Table 61: Regulation Pertaining AI Medical Diagnostics Across Countries
Table 62: Siemens Healthcare GmbH Patents, 2019-2021
Table 63: General Electric Co. Patents, 2019-2021
Table 64: Patents Granted to Other Major Market Players, 2019-2021
Table 65: Start-ups Founded in the AI Medical Diagnostics Industry, 2020-2021
Table 66: Major Market Strategies in Global Market for AI Medical Diagnostics, 2018-2021
Table 67: List of Partnerships, Collaborations, Agreements and Contracts, 2020-2021
Table 68: List of FDA, CE Mark and EU Approvals, 2020 and 2021
Table 69: Aidoc Medical Ltd.: Product Portfolio
Table 70: Aidoc Medical Ltd.: Strategies and Development
Table 71: Arterys Inc.: Product Portfolio
Table 72: Arterys Inc.: Strategies and Development
Table 73: Behold.ai: Product Portfolio
Table 74: Behold.ai: Strategies and Development
Table 75: Butterfly Network: Product Portfolio
Table 76: Butterfly Network: Strategies and Development
Table 77: Canon Medical: Company Financials, 2019 and 2020
Table 78: Canon Medical System: Product Portfolio
Table 79: Canon Medical System: Strategies and Development
Table 80: Caption Health: Product Portfolio
Table 81: Caption Health: Strategies and Developments
Table 82: DeepMind: Company Financials, 2020-2019
Table 83: DeepMind: Product Portfolio
Table 84: Digital Diagnostics: Product Portfolio
Table 85: Digital Diagnostics: Strategies and Developments
Table 86: Enlitic Inc.: Product Portfolio
Table 87: Fujifilm Holding Corp.: Company Financials, 2019 and 2020
Table 88: Fujifilm Holding Corp.: Product Portfolio
Table 89: Fujifilm Holding Corp.: Strategies and Developments
Table 90: GE: Financial Performance, 2019 and 2020
Table 91: GE Healthcare: Product Portfolio
Table 92: GE Healthcare: Strategies and Developments
Table 93: Heuron Co., Ltd.: Product Portfolio
Table 94: Heuron Co., Ltd.: Strategies and Developments
Table 95: Imagen: Product Portfolio
Table 96: IBM Corp.: Company Financials, 2019 and 2020
Table 97: IBM Corp.: Product Portfolio
Table 98: IBM Corp.: Strategies and Developments
Table 99: iCarbonX: Product Portfolio
Table 100: Intel Corp.: Product Portfolio in AI Diagnostics
Table 101: Intel Corp.: Company Financials, 2019 and 2020
Table 102: Medtronic Plc: Financials, 2019 and 2020
Table 103: Medtronic Plc: Product Portfolio
Table 104: Medtronic Plc: Strategies and Developments
Table 105: Microsoft Corp.: Financials, 2019 and 2020
Table 106: Microsoft Corp.: Product Portfolio
Table 107: Microsoft Corp.: Strategies and Developments
Table 108: Nano-X AI: Product Portfolio
Table 109: Nano-X AI: Strategies and Developments
Table 110: Nano-X AI: MSaaS Agreements in 2020
Table 111: Nvidia: Company Financials, 2019 and 2020
Table 112: Nvidia: Product Portfolio
Table 113: NVIDIA: Strategies and Developments
Table 114: Phillips Healthcare: Financials, 2019 and 2020
Table 115: Philips Healthcare: Product Portfolio in AI in Diagnostics
Table 116: Phillips Healthcare: Strategies and Developments
Table 117: Qure.ai: Product Portfolio
Table 118: Qure.ai: Strategic Developments
Table 119: F. Hoffmann-La Roche Ltd.: Financials, 2019 and 2020
Table 120: F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2019 and 2020
Table 121: F. Hoffmann-La Roche Ltd.: Product Portfolio in AI Diagnostics
Table 122: F. Hoffmann-La Roche Ltd.: Recent Developments
Table 123: Samsung Electronics Inc.: Product Portfolio
Table 124: Samsung Electronics Inc.: Strategic Developments
Table 125: Siemens Healthcare GmbH: Product Segments
Table 126: Siemens Healthcare GmbH: AI Diagnostics Products
Table 127: Siemens Healthcare GmbH: Financials, 2019 and 2020
Table 128: Subtle Medical, Inc.: Product Portfolio
Table 129: Subtle Medical, Inc.: Strategies and Developments
Table 130: Synapsica: Product Portfolio
Table 131: Synapsica: Strategies and Developments
Table 132: Xilinx, Inc.: Company Financials, 2019 and 2020
Table 133: Xilinx, Inc.: Product Portfolio
Table 134: Xilinx, Inc.: Strategies and Developments
Summary Table: Global Market for AI Medical Diagnostics, by Region, Through 2026
Table 1: FDA-Cleared AI Radiology and Other Imaging Modalities in the U.S., 2018-2021
Table 2: FDA-Approved AI Algorithms for Radiology and Medical Imaging in the U.S., 2018-2021
Table 3: Global Leading Causes of Burden of Disease, 2004 and 2030
Table 4: Cancer Statistics Across Major Asian Countries, by Cancer Site/Type, 2020
Table 5: Global Market for AI Medical Diagnostics, by Component, Through 2026
Table 6: Global Market for AI Software in Medical Diagnostics, by Region, Through 2026
Table 7: Global Market for AI Services in Medical Diagnostics, by Region, Through 2026
Table 8: Global Market for AI Hardware in Medical Diagnostics, by Region, Through 2026
Table 9: Global Market for AI Medical Diagnostics, by Medical Specialty Application Area, Through 2026
Table 10: Global Deaths from Cancer, 2015 and 2030
Table 11: Global Market for AI Medical Diagnostics in Oncology, by Region, Through 2026
Table 12: Recent Examples of Machine Learning in Cardiology
Table 13: Global Deaths from CVD, 2015 and 2030
Table 14: Global Market for AI Medical Diagnostics in Cardiology, by Region, Through 2026
Table 15: Number of DALYs for Neurological Disorders and as Share of Global DALYs Projected for 2005 and 2030
Table 16: Deaths Attributable to Neurological Disorders, 2005 and 2030
Table 17: Global Market for AI Medical Diagnostics in Neurology, by Region, Through 2026
Table 18: Global Percentage Distribution of Population Aged Above 65, by Region, 2015 and 2050
Table 19: Global Market for AI Medical Diagnostics in Orthopedics, by Region, Through 2026
Table 20: Global Market for AI Medical Diagnostics in Other Disease Treatments, by Region, Through 2026
Table 21: Global Market for AI Medical Diagnostics, by End User, Through 2026
Table 22: Number of Hospitals in the U.S., by Type, 2020
Table 23: Global Market for AI in Hospitals and Clinics, by Region, Through 2026
Table 24: Global Market for AI Medical Diagnostics in Diagnostic Imaging Centers and Diagnostic Laboratories, by Region, Through 2026
Table 25: Global Market for AI Medical Diagnostics, by Modality, Through 2026
Table 26: Global Market for AI-Based MRI Scans, by Region, Through 2026
Table 27: Global Market for AI-Based CT Scans, by Region, Through 2026
Table 28: Some Major Uses of Ultrasound
Table 29: Global Market for AI-Based Ultrasound, by Region, Through 2026
Table 30: Global Market for AI-Based X-Rays, by Region, Through 2026
Table 31: Global Market for AI-Based Other Imaging Techniques, by Region, Through 2026
Table 32: Global Market for AI Medical Diagnostics, by Region, Through 2026
Table 33: North American Market for AI Medical Diagnostics, by Component, Through 2026
Table 34: North American Market for AI Medical Diagnostics, by Medical Specialty Application Area, Through 2026
Table 35: North American Market for AI Medical Diagnostics, by Modality, Through 2026
Table 36: North American Market for AI Medical Diagnostics, by End User, Through 2026
Table 37: North American Market for AI Medical Diagnostics, by Country, Through 2026
Table 38: Top Funded AI Start-ups in the United States, 2021
Table 39: Confirmed Cases of COVID-19 in Europe, by Country, as of December, 2021
Table 40: European Market for AI Medical Diagnostics, by Component, Through 2026
Table 41: European Market for AI Medical Diagnostics, by Medical Specialty Application Area, Through 2026
Table 42: European Market for AI Medical Diagnostics, by Modality, Through 2026
Table 43: European Market for AI Medical Diagnostics, by End User, Through 2026
Table 44: European Market for AI Medical Diagnostics, by Country, Through 2026
Table 45: Start-ups in the German Market for AI Medical Diagnostics
Table 46: Start-ups in the French Market for AI Medical Diagnostics
Table 47: Start-ups in the Spanish Market for AI Medical Diagnostics
Table 48: Start-ups in the Rest of European Market for AI Medical Diagnostics
Table 49: Asia-Pacific Market for AI Medical Diagnostics, by Component, Through 2026
Table 50: Asia-Pacific Market for AI Medical Diagnostics, by Medical Specialty Application Area, Through 2026
Table 51: Asia-Pacific Market for AI Medical Diagnostics, by Modality, Through 2026
Table 52: Asia-Pacific Market for AI Medical Diagnostics, by End User, Through 2026
Table 53: Asia-Pacific Market for AI Medical Diagnostics, by Countries, Through 2026
Table 54: Japanese Market Statistics
Table 55: Number of New Cancer Cases in Japan in Both Sexes, by All Age Groups, 2020
Table 56: Funding of AI Diagnostics Start-ups in Rest of Asia-Pacific Countries
Table 57: Rest of the World Market for AI Medical Diagnostics, by Component, Through 2026
Table 58: Rest of the World Market for AI Medical Diagnostics, by Medical Specialty Application Area, Through 2026
Table 59: Rest of the World Market for AI Medical Diagnostics, by Modality, Through 2026
Table 60: Rest of the World Market for AI Medical Diagnostics, by End User, Through 2026
Table 61: Regulation Pertaining AI Medical Diagnostics Across Countries
Table 62: Siemens Healthcare GmbH Patents, 2019-2021
Table 63: General Electric Co. Patents, 2019-2021
Table 64: Patents Granted to Other Major Market Players, 2019-2021
Table 65: Start-ups Founded in the AI Medical Diagnostics Industry, 2020-2021
Table 66: Major Market Strategies in Global Market for AI Medical Diagnostics, 2018-2021
Table 67: List of Partnerships, Collaborations, Agreements and Contracts, 2020-2021
Table 68: List of FDA, CE Mark and EU Approvals, 2020 and 2021
Table 69: Aidoc Medical Ltd.: Product Portfolio
Table 70: Aidoc Medical Ltd.: Strategies and Development
Table 71: Arterys Inc.: Product Portfolio
Table 72: Arterys Inc.: Strategies and Development
Table 73: Behold.ai: Product Portfolio
Table 74: Behold.ai: Strategies and Development
Table 75: Butterfly Network: Product Portfolio
Table 76: Butterfly Network: Strategies and Development
Table 77: Canon Medical: Company Financials, 2019 and 2020
Table 78: Canon Medical System: Product Portfolio
Table 79: Canon Medical System: Strategies and Development
Table 80: Caption Health: Product Portfolio
Table 81: Caption Health: Strategies and Developments
Table 82: DeepMind: Company Financials, 2020-2019
Table 83: DeepMind: Product Portfolio
Table 84: Digital Diagnostics: Product Portfolio
Table 85: Digital Diagnostics: Strategies and Developments
Table 86: Enlitic Inc.: Product Portfolio
Table 87: Fujifilm Holding Corp.: Company Financials, 2019 and 2020
Table 88: Fujifilm Holding Corp.: Product Portfolio
Table 89: Fujifilm Holding Corp.: Strategies and Developments
Table 90: GE: Financial Performance, 2019 and 2020
Table 91: GE Healthcare: Product Portfolio
Table 92: GE Healthcare: Strategies and Developments
Table 93: Heuron Co., Ltd.: Product Portfolio
Table 94: Heuron Co., Ltd.: Strategies and Developments
Table 95: Imagen: Product Portfolio
Table 96: IBM Corp.: Company Financials, 2019 and 2020
Table 97: IBM Corp.: Product Portfolio
Table 98: IBM Corp.: Strategies and Developments
Table 99: iCarbonX: Product Portfolio
Table 100: Intel Corp.: Product Portfolio in AI Diagnostics
Table 101: Intel Corp.: Company Financials, 2019 and 2020
Table 102: Medtronic Plc: Financials, 2019 and 2020
Table 103: Medtronic Plc: Product Portfolio
Table 104: Medtronic Plc: Strategies and Developments
Table 105: Microsoft Corp.: Financials, 2019 and 2020
Table 106: Microsoft Corp.: Product Portfolio
Table 107: Microsoft Corp.: Strategies and Developments
Table 108: Nano-X AI: Product Portfolio
Table 109: Nano-X AI: Strategies and Developments
Table 110: Nano-X AI: MSaaS Agreements in 2020
Table 111: Nvidia: Company Financials, 2019 and 2020
Table 112: Nvidia: Product Portfolio
Table 113: NVIDIA: Strategies and Developments
Table 114: Phillips Healthcare: Financials, 2019 and 2020
Table 115: Philips Healthcare: Product Portfolio in AI in Diagnostics
Table 116: Phillips Healthcare: Strategies and Developments
Table 117: Qure.ai: Product Portfolio
Table 118: Qure.ai: Strategic Developments
Table 119: F. Hoffmann-La Roche Ltd.: Financials, 2019 and 2020
Table 120: F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2019 and 2020
Table 121: F. Hoffmann-La Roche Ltd.: Product Portfolio in AI Diagnostics
Table 122: F. Hoffmann-La Roche Ltd.: Recent Developments
Table 123: Samsung Electronics Inc.: Product Portfolio
Table 124: Samsung Electronics Inc.: Strategic Developments
Table 125: Siemens Healthcare GmbH: Product Segments
Table 126: Siemens Healthcare GmbH: AI Diagnostics Products
Table 127: Siemens Healthcare GmbH: Financials, 2019 and 2020
Table 128: Subtle Medical, Inc.: Product Portfolio
Table 129: Subtle Medical, Inc.: Strategies and Developments
Table 130: Synapsica: Product Portfolio
Table 131: Synapsica: Strategies and Developments
Table 132: Xilinx, Inc.: Company Financials, 2019 and 2020
Table 133: Xilinx, Inc.: Product Portfolio
Table 134: Xilinx, Inc.: Strategies and Developments
LIST OF FIGURES
Summary Figure A: Global Market for AI Medical Diagnostics, by Region, 2019-2026
Summary Figure B: Global Market Shares of AI Medical Diagnostics, by Region, 2020
Figure 1: Snapshot of the Global Market for AI Medical Diagnostics
Figure 2: Global Market for Artificial Intelligence in Medical Diagnostics: Industry Process Flow
Figure 3: FDA-Approved AI Radiology and Other Imaging Medical Products in the U.S., by Modality, 2018-2021
Figure 4: FDA-Approved AI Radiology and Other Imaging Medical Products in the U.S., by Medical Specialty, 2018-2021
Figure 5: FDA-Approved AI Algorithms for Medical Diagnostics in the U.S., 1995-2021
Figure 6: Shares of FDA-Approved AI Algorithms for Medical Diagnostics in the U.S., by Company, 2018-2021
Figure 7: FDA-Approved AI Algorithms in the U.S., by Medical Specialty, 2018-2021
Figure 8: Global Funding in Health-Tech Companies, 2010-2019
Figure 9: Global Projections for Three Chronic Diseases, 2005-2030
Figure 10: Global Market for AI Medical Diagnostics, by Component, 2019-2026
Figure 11: Global Market Shares of AI Medical Diagnostics, by Component, 2020
Figure 12: Global Market for AI Software in Medical Diagnostics, 2019-2026
Figure 13: Global Market for AI Software in Medical Diagnostics, by Region, 2019-2026
Figure 14: Global Market for AI Services in Medical Diagnostics, 2019-2026
Figure 15: Global Market for AI Services in Medical Diagnostics, by Region, 2019-2026
Figure 16: Global Market for AI Hardware in Medical Diagnostics, 2019-2026
Figure 17: Global Market for AI Hardware in Medical Diagnostics, by Region, 2019-2026
Figure 18: Global Market for AI Medical Diagnostics, by Medical Specialty Application Area, 2019-2026
Figure 19: Global Market Shares of AI Medical Diagnostics, by Medical Specialty Application Area, 2020
Figure 20: Global Deaths from Cancer, 2015 and 2030
Figure 21: Global Market for AI Medical Diagnostics in Oncology, 2019-2026
Figure 22: Global Market for AI Medical Diagnostics in Oncology, by Region, 2019-2026
Figure 23: Global Deaths from CVD, 2015 and 2030
Figure 24: Global Market for AI Medical Diagnostics in Cardiology, 2019-2026
Figure 25: Global Market for AI Medical Diagnostics in Cardiology, by Region, 2019-2026
Figure 26: Global Market for AI Medical Diagnostics in Neurology, 2019-2026
Figure 27: Global Market for AI Medical Diagnostics in Neurology, by Region, 2019-2026
Figure 28: Global Percentage Distribution of Population Aged Above 65, by Region, 2015 and 2050
Figure 29: Global Market for AI Medical Diagnostics in Orthopedics, 2019-2026
Figure 30: Global Market for AI Medical Diagnostics in Orthopedics, by Region, 2019-2026
Figure 31: Global Market for AI Medical Diagnostics in Other Disease Treatments, 2019-2026
Figure 32: Global Market for AI Medical Diagnostics in Other Disease Treatments, by Region, 2019-2026
Figure 33: Global Market for AI Medical Diagnostics, by End User, 2019-2026
Figure 34: Global Market Shares of AI Medical Diagnostics, by End User, 2020
Figure 35: Number of Hospitals in the U.S., by Type, 2020
Figure 36: Global Market for AI in Hospitals and Clinics, 2019-2026
Figure 37: Global Market for AI in Hospital and Clinics, by Region, 2019-2026
Figure 38: Global Market for AI Medical Diagnostics in Diagnostic Imaging Centers and Diagnostic Laboratories, 2019-2026
Figure 39: Global Market for AI Medical Diagnostics in Diagnostic Imaging Centers and Diagnostic Laboratories, by Region, 2019-2026
Figure 40: Global Market for AI Medical Diagnostics, by Modality, 2020
Figure 41: Global Market Shares of AI Medical Diagnostics, by Modality, 2020
Figure 42: Global Market for AI-Based MRI Scans, 2019-2026
Figure 43: Global Market for AI-Based MRI Scans, by Region, 2019-2026
Figure 44: Global Market for AI-Based CT Scans, 2019-2026
Figure 45: Global Market for AI-Based CT Scans, by Region, 2019-2026
Figure 46: Global Market for AI-Based Ultrasound, 2019-2026
Figure 47: Global Market for AI-Based Ultrasound, by Region, 2019-2026
Figure 48: Global Market for AI-Based X-Rays, 2019-2026
Figure 49: Global Market for AI-Based X-Rays, by Region, 2019-2026
Figure 50: Annual Revenues in the Endoscopy Devices Market, 2015-2024
Figure 51: Global Market for AI-Based Other Imaging Techniques, 2019-2026
Figure 52: Global Market for AI-Based Other Imaging Techniques, by Region, 2019-2026
Figure 53: Global Market for AI Medical Diagnostics, by Region, 2019-2026
Figure 54: Global Market Shares of AI Medical Diagnostics, by Region, 2020
Figure 55: North American Market Shares of AI Medical Diagnostics, by Country, 2020
Figure 56: U.S. Market for AI Medical Diagnostics, 2019-2026
Figure 57: Canadian Market for AI Medical Diagnostics, 2019-2026
Figure 58: Rising Geriatric Population in Germany, 2000-2030
Figure 59: German Market for AI Medical Diagnostics, 2019-2026
Figure 60: United Kingdom Market for AI Medical Diagnostics, 2019-2026
Figure 61: French Market for AI Medical Diagnostics, 2019-2026
Figure 62: Italian Market for AI Medical Diagnostics, 2019-2026
Figure 63: Spanish Market for AI Medical Diagnostics, 2019-2026
Figure 64: Rest of the European Market for AI Medical Diagnostics, 2019-2026
Figure 65: Allocation of Diagnosed Infectious Diseases in Selected Countries, by Gender, as of 2019
Figure 66: Chinese Market for AI Medical Diagnostics, 2019-2026
Figure 67: Japanese Market for AI Medical Diagnostics, 2019-2026
Figure 68: Indian Market for AI Medical Diagnostics, 2019-2026
Figure 69: Rest of Asia-Pacific Market for AI Medical Diagnostics, 2019-2026
Figure 70: Rest of the World Market for AI Medical Diagnostics, 2019-2026
Figure 71: Patents Granted to Siemens Healthcare GmbH, 2019-2021
Figure 72: Share of Patents Granted to Siemens Healthcare GmbH, by Geography, 2019-2021
Figure 73: Patents Granted to General Electric Co., 2019-2021
Figure 74: Patents Granted to Other Major Players, 2019-2021
Figure 75: Share of Patents Granted on AI Medical Diagnostics, by Geography, 2019-2021
Figure 76: Share of Start-ups Founded in the AI Medical Diagnostics Industry, by Region, 2020-2021
Figure 77: Key Strategies Followed by Companies, by Type of Strategy, 2018-2021
Figure 78: Key Strategies Followed by Companies, by Type of Strategy, 2018-2021
Figure 79: Number of Strategic Actions Followed, by Company, 2018-2021
Figure 80: Canon Medical: Revenue Share, by Region, 2020
Figure 81: GE: Revenue Share, by Business Segment, 2020
Figure 82: GE Healthcare: Revenue Share, by Region, 2020
Figure 83: IBM Corp.: Revenue Share, by Business Segment in AI Diagnostics, 2020
Figure 84: Intel Corp.: Revenue Share, by Country, 2020
Figure 85: Microsoft Corp.: Revenue Share, by Geography, 2020
Figure 86: Phillips Healthcare: Revenue Share, by Geography, 2020
Figure 87: F. Hoffmann-La Roche Ltd.: Revenue Share, by Segment, 2019
Figure 88: F. Hoffmann-La Roche Ltd.: Revenue Share, by Geography, 2019
Figure 89: Siemens Healthcare GmbH: Revenue Share, by Business Segment, 2020
Figure 90: Siemens Healthcare GmbH: Revenue Share, by Region, 2019
Figure 91: Xilinx, Inc.: Revenue Share, by Region, 2020
Summary Figure A: Global Market for AI Medical Diagnostics, by Region, 2019-2026
Summary Figure B: Global Market Shares of AI Medical Diagnostics, by Region, 2020
Figure 1: Snapshot of the Global Market for AI Medical Diagnostics
Figure 2: Global Market for Artificial Intelligence in Medical Diagnostics: Industry Process Flow
Figure 3: FDA-Approved AI Radiology and Other Imaging Medical Products in the U.S., by Modality, 2018-2021
Figure 4: FDA-Approved AI Radiology and Other Imaging Medical Products in the U.S., by Medical Specialty, 2018-2021
Figure 5: FDA-Approved AI Algorithms for Medical Diagnostics in the U.S., 1995-2021
Figure 6: Shares of FDA-Approved AI Algorithms for Medical Diagnostics in the U.S., by Company, 2018-2021
Figure 7: FDA-Approved AI Algorithms in the U.S., by Medical Specialty, 2018-2021
Figure 8: Global Funding in Health-Tech Companies, 2010-2019
Figure 9: Global Projections for Three Chronic Diseases, 2005-2030
Figure 10: Global Market for AI Medical Diagnostics, by Component, 2019-2026
Figure 11: Global Market Shares of AI Medical Diagnostics, by Component, 2020
Figure 12: Global Market for AI Software in Medical Diagnostics, 2019-2026
Figure 13: Global Market for AI Software in Medical Diagnostics, by Region, 2019-2026
Figure 14: Global Market for AI Services in Medical Diagnostics, 2019-2026
Figure 15: Global Market for AI Services in Medical Diagnostics, by Region, 2019-2026
Figure 16: Global Market for AI Hardware in Medical Diagnostics, 2019-2026
Figure 17: Global Market for AI Hardware in Medical Diagnostics, by Region, 2019-2026
Figure 18: Global Market for AI Medical Diagnostics, by Medical Specialty Application Area, 2019-2026
Figure 19: Global Market Shares of AI Medical Diagnostics, by Medical Specialty Application Area, 2020
Figure 20: Global Deaths from Cancer, 2015 and 2030
Figure 21: Global Market for AI Medical Diagnostics in Oncology, 2019-2026
Figure 22: Global Market for AI Medical Diagnostics in Oncology, by Region, 2019-2026
Figure 23: Global Deaths from CVD, 2015 and 2030
Figure 24: Global Market for AI Medical Diagnostics in Cardiology, 2019-2026
Figure 25: Global Market for AI Medical Diagnostics in Cardiology, by Region, 2019-2026
Figure 26: Global Market for AI Medical Diagnostics in Neurology, 2019-2026
Figure 27: Global Market for AI Medical Diagnostics in Neurology, by Region, 2019-2026
Figure 28: Global Percentage Distribution of Population Aged Above 65, by Region, 2015 and 2050
Figure 29: Global Market for AI Medical Diagnostics in Orthopedics, 2019-2026
Figure 30: Global Market for AI Medical Diagnostics in Orthopedics, by Region, 2019-2026
Figure 31: Global Market for AI Medical Diagnostics in Other Disease Treatments, 2019-2026
Figure 32: Global Market for AI Medical Diagnostics in Other Disease Treatments, by Region, 2019-2026
Figure 33: Global Market for AI Medical Diagnostics, by End User, 2019-2026
Figure 34: Global Market Shares of AI Medical Diagnostics, by End User, 2020
Figure 35: Number of Hospitals in the U.S., by Type, 2020
Figure 36: Global Market for AI in Hospitals and Clinics, 2019-2026
Figure 37: Global Market for AI in Hospital and Clinics, by Region, 2019-2026
Figure 38: Global Market for AI Medical Diagnostics in Diagnostic Imaging Centers and Diagnostic Laboratories, 2019-2026
Figure 39: Global Market for AI Medical Diagnostics in Diagnostic Imaging Centers and Diagnostic Laboratories, by Region, 2019-2026
Figure 40: Global Market for AI Medical Diagnostics, by Modality, 2020
Figure 41: Global Market Shares of AI Medical Diagnostics, by Modality, 2020
Figure 42: Global Market for AI-Based MRI Scans, 2019-2026
Figure 43: Global Market for AI-Based MRI Scans, by Region, 2019-2026
Figure 44: Global Market for AI-Based CT Scans, 2019-2026
Figure 45: Global Market for AI-Based CT Scans, by Region, 2019-2026
Figure 46: Global Market for AI-Based Ultrasound, 2019-2026
Figure 47: Global Market for AI-Based Ultrasound, by Region, 2019-2026
Figure 48: Global Market for AI-Based X-Rays, 2019-2026
Figure 49: Global Market for AI-Based X-Rays, by Region, 2019-2026
Figure 50: Annual Revenues in the Endoscopy Devices Market, 2015-2024
Figure 51: Global Market for AI-Based Other Imaging Techniques, 2019-2026
Figure 52: Global Market for AI-Based Other Imaging Techniques, by Region, 2019-2026
Figure 53: Global Market for AI Medical Diagnostics, by Region, 2019-2026
Figure 54: Global Market Shares of AI Medical Diagnostics, by Region, 2020
Figure 55: North American Market Shares of AI Medical Diagnostics, by Country, 2020
Figure 56: U.S. Market for AI Medical Diagnostics, 2019-2026
Figure 57: Canadian Market for AI Medical Diagnostics, 2019-2026
Figure 58: Rising Geriatric Population in Germany, 2000-2030
Figure 59: German Market for AI Medical Diagnostics, 2019-2026
Figure 60: United Kingdom Market for AI Medical Diagnostics, 2019-2026
Figure 61: French Market for AI Medical Diagnostics, 2019-2026
Figure 62: Italian Market for AI Medical Diagnostics, 2019-2026
Figure 63: Spanish Market for AI Medical Diagnostics, 2019-2026
Figure 64: Rest of the European Market for AI Medical Diagnostics, 2019-2026
Figure 65: Allocation of Diagnosed Infectious Diseases in Selected Countries, by Gender, as of 2019
Figure 66: Chinese Market for AI Medical Diagnostics, 2019-2026
Figure 67: Japanese Market for AI Medical Diagnostics, 2019-2026
Figure 68: Indian Market for AI Medical Diagnostics, 2019-2026
Figure 69: Rest of Asia-Pacific Market for AI Medical Diagnostics, 2019-2026
Figure 70: Rest of the World Market for AI Medical Diagnostics, 2019-2026
Figure 71: Patents Granted to Siemens Healthcare GmbH, 2019-2021
Figure 72: Share of Patents Granted to Siemens Healthcare GmbH, by Geography, 2019-2021
Figure 73: Patents Granted to General Electric Co., 2019-2021
Figure 74: Patents Granted to Other Major Players, 2019-2021
Figure 75: Share of Patents Granted on AI Medical Diagnostics, by Geography, 2019-2021
Figure 76: Share of Start-ups Founded in the AI Medical Diagnostics Industry, by Region, 2020-2021
Figure 77: Key Strategies Followed by Companies, by Type of Strategy, 2018-2021
Figure 78: Key Strategies Followed by Companies, by Type of Strategy, 2018-2021
Figure 79: Number of Strategic Actions Followed, by Company, 2018-2021
Figure 80: Canon Medical: Revenue Share, by Region, 2020
Figure 81: GE: Revenue Share, by Business Segment, 2020
Figure 82: GE Healthcare: Revenue Share, by Region, 2020
Figure 83: IBM Corp.: Revenue Share, by Business Segment in AI Diagnostics, 2020
Figure 84: Intel Corp.: Revenue Share, by Country, 2020
Figure 85: Microsoft Corp.: Revenue Share, by Geography, 2020
Figure 86: Phillips Healthcare: Revenue Share, by Geography, 2020
Figure 87: F. Hoffmann-La Roche Ltd.: Revenue Share, by Segment, 2019
Figure 88: F. Hoffmann-La Roche Ltd.: Revenue Share, by Geography, 2019
Figure 89: Siemens Healthcare GmbH: Revenue Share, by Business Segment, 2020
Figure 90: Siemens Healthcare GmbH: Revenue Share, by Region, 2019
Figure 91: Xilinx, Inc.: Revenue Share, by Region, 2020
